# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-019018
Filing Date
2024-05-14
Accepted
2024-05-14 06:04:04
Documents
64
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-ka.htm iXBRL | 10-K/A | 1515095
2 |  | ex31-1.htm | EX-31.1 | 12319
3 |  | ex31-2.htm | EX-31.2 | 12971
4 |  | ex32-1.htm | EX-32.1 | 8042
5 |  | form10-ka_001.jpg | GRAPHIC | 22820
6 |  | form10-ka_002.jpg | GRAPHIC | 12061
7 |  | form10-ka_003.jpg | GRAPHIC | 20362
8 |  | form10-ka_004.jpg | GRAPHIC | 17245
| Complete submission text file | 0001493152-24-019018.txt |  | 5550297

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | ptix-20231231.xsd | EX-101.SCH | 34612
10 | XBRL CALCULATION FILE | ptix-20231231_cal.xml | EX-101.CAL | 46708
11 | XBRL DEFINITION FILE | ptix-20231231_def.xml | EX-101.DEF | 180426
12 | XBRL LABEL FILE | ptix-20231231_lab.xml | EX-101.LAB | 354813
13 | XBRL PRESENTATION FILE | ptix-20231231_pre.xml | EX-101.PRE | 278430
68 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-ka_htm.xml | XML | 581538

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12555 | Film No.: 24941290
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)